Proposed Board

Proposed Board Stockholm, Sweden - Gambro AB (OM Stockholm Exchange: GAMBaST, GAMBbST), a leading international medical technology and healthcare company, today made the following announcement. At the Gambro AB Annual General Meeting on March 27, 2000 the following Board Members will be proposed for reelection: Claes Dahlbäck, Gösta Gahrton, Peter H Grassmann, Juha P Kokko, Håkan Mogren, Sven Nyman, Björn Svedberg and Mikael Lilius. The proposals regarding the composition of the Board are supported by shareholders representing more than 40 percent of the total number of voting rights in the company. For further information please contact: Bengt Modéer, Senior Vice President, Corporate Communications, tel. +46-8- 613 65 00, +46-70-513 65 33 Board members proposed for reelection Claes Dahlbäck, Chairman. Born 1947. Elected 1998. Chairman of the Boards of Stora Enso, Vin & Sprit and EQT. Vice Chairman of Investor and Skandinaviska Enskilda Banken. Gösta Gahrton. Born 1932. Elected 1998. Professor at the Karolinska Institutet. Former head of the Department of Medicine at Huddinge Hospital and Chairman of the Karolinska Institutet's Nobel Prize Committee. Vice Chairman of the International Society of Haematology. Member of the Boards of, among others, Marianne and Marcus Wallenberg's Foundation, and Deputy Member of the Board of the King Gustav V Jubilee Fund. Peter H. Grassmann. Born 1939. Elected 1998. President and CEO of Carl Zeiss, Oberkochen, Germany. Member of the Board of ASM-L Holding N.V., Netherlands. Member of the Advisory Boards of Allianz and Deutsche Bank, Germany. Chairman of Carl Zeiss Co. Ltd., Tokyo and Carl Zeiss Inc., New York, among other positions. Juha P. Kokko. Born 1937. Elected 1998. Asa G. Candler Professor of Medicine and Associate Dean for Clinical Research, Emory University, Atlanta, Georgia, USA. Former Chairman of Medicine at Emory University; Chief of Nephrology, University of Texas, Dallas, Texas, USA; Past President American Society of Nephrology, and Board Member of Discovery Therapeutics, Richmond, Virginia, USA, among other positions. Mikael Lilius. Born 1949. Elected 1991. President and CEO of Gambro. Member of the Boards of Ratos, Sweden and Huhtamäki Oy, Instrumentarium Oy and Perlos Oy, Finland. Håkan Mogren, Vice Chairman. Born 1944. Elected 1996. Deputy Chairman of AstraZeneca PLC. Chairman of the Board of the Research Institute of Industrial Economics. Vice Chairman of the Social and Economic Council (Skandinaviska Enskilda Banken). Member of the Boards of AstraZeneca PLC, Investor and the Federation of Swedish Industries. Sven Nyman. Born 1959. Elected 1998. Managing Director of Investor. Member of the Boards of Försäkringsbolaget SPP, Diligentia and OM Gruppen. Björn Svedberg. Born 1937. Elected 1997. Member of the Boards of, among others, Investor, SAAB and Scania. Chairman of Chalmers University of Technology and Chairman of the Royal Swedish Academy of Engineering Sciences. ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/2000/02/23/20000223BIT00730/bit0001.doc http://www.bit.se/bitonline/2000/02/23/20000223BIT00730/bit0002.pdf

About Us

Gambro is a global medical technology and healthcare company with leading positions in renal care - services and products - and blood component technology. The group, with revenue of approximately SEK 18 billion (USD 2.2 billion), has approximately 17,000 employees in some 40 countries.

Subscribe